Fumoy,
It has been a long time between drinks for many small cap stem cell companies - but like the tide these things change. Cynata has brilliant timing in this regard.
There will be a lot of people and brokers running there ruler over cyp thinking what added value could this company have to an existing stem cell company and for that matter specific treatment.
$2-4 target for cynata, page-5
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.015(7.69%) |
Mkt cap ! $32.52M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $4.623K | 25.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15232 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 17000 | 1 |
View Market Depth
| Last trade - 12.01pm 11/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |